The Match Out: Shares move higher following record CBA result

The daily Match Out for Wednesday 9 August with James Gerrish of Market Matters.
James Gerrish

Market Matters

Shares started slowly today but found their mojo into the afternoon, finishing near highs on the back of strength in the banks. There was little change ahead of inflation data coming out of China mid-morning, but when that passed without concern, the focus returned to CBA’s record result.

  • The ASX 200 finished up +26pts/ +0.37% at 7338
  • The Financials sector was best on ground (+.21%) while Telcos (+0.94%) & Tech (+0.87%) were also strong.
  • Healthcare (-0.89%) continued to lag. Real Estate (-0.72%) and Utilities (-0.27%) were the remaining sectors to close lower.
  • China CPI figure came in at -0.3% YoY, broadly in line with expectations. The market is looking for additional stimulus measures now which would support the miners, though timing is more difficult to predict.
  • Commonwealth Bank (ASX: CBA) +2.58% delivered a strong FY23 result, a small beat to expectations and a surprise $1b buyback. More on that below.
  • Lead Portfolio Manager James Gerrish was on Ausbiz this morning covering the result from CBA - Click here to watch
  • Suncorp (ASX: SUN) -1.53% saw a broadly inline headline result with profit of $1.25b, though a strong Aus Insurance performance was offset by weaker bank and NZ result.
  • Bowen Coking Coal (ASX: BCB) +10.71% found some form with an improved shipping update + a resource increase.
  • InvoCare (ASX: IVC) +5.94% has accepted a revised $12.70/sh bid from TPG Capital, valuing the company at $2.2b.
  • Syrah Resources (ASX: SYR) +1.56% signed an agreement with Samsung to provide graphite for their Batteries.
  • Iron Ore was flat in Asia today with BHP (ASX: BHP) and Fortescue (ASX: FMG) slightly higher, though RIO fell.
  • Gold was trading around $US1930 in Asian trade today, marginally higher on the day.
  • Asian stocks were soft, Hong Kong down -0.25% and Japan & China down around -0.50% each
  • US Futures are all up, around +0.10%
  • July Performance for the Market Matters Portfolios – Click Here to Watch
  • We have a close eye on AGL Energy (ASX: AGL) reporting earnings tomorrow as well as AMP, Megaport (ASX: MP1), QBE Insurance (ASX: QBE) and Boral (ASX: BLD) among others. Download the Market Matters Reporting Calendar Here
  • Stocks we own in the International Equities Portfolio with results this week: Barrick Gold (NYSE: GOLD), Alibaba (NASDAQ: BABA), The Trade Desk (NYSE: TTD) & Yeti Holdings (NYSE: YETI).

ASX200

Suncorp (ASX: SUN) $13.54

SUN -1.53%: Fell today despite announcing cash earnings of $1,254m in line with consensus, however, the composition of the result was soft and their guidance was a touch light, particularly within their banking division which had a tougher period, which is likely to continue. The 27c final dividend was also a long way below consensus (40c). Insurance earnings were strong, at $755m and above $687m expected, however, guidance was less upbeat than current market expectations sit. Within the banking division, net interest margins (NIMs) were 1.96% while they’ve guided to the bottom end of the 1.85-1.95% range for FY24 as costs increase.

A mixed result from SUN, okay from insurance, soft from the bank

Suncorp (ASX: SUN)

Commonwealth Bank (ASX: CBA) $104.85

CBA +2.58%: Australia’s 2nd largest company (behind BHP) released FY23 results this morning that were a modest beat to expectations as margins improved 17bps to 2.07%, ahead of the 2.05% consensus expectations. Operating income of $27.24bn was up 13% while cash earnings of $10.164bn increased 6% and were in line with $10.17bn forecast. Margins were a focus leading into today’s result and they’ve done well here despite the competition, although we did think the competitive backdrop in mortgages and more importantly retail deposits have become more rational over recent months.

Earnings per share (EPS) of $6.015 was pleasing and a slight beat while the FY dividend of $4.50 was ahead of the $4.33 consensus (2H dividend of $2.40), and is based on a 74% payout ratio. Capital levels are strong and above expectations while they did experience a reasonable uplift in provisioning for bad loans. We were not expecting any new buy-backs, however, they did announce an additional $1bn on-market program which reflects their strong capital position.

The commentary was cautious, with CEO Matt Comyn saying….We are seeing consumer demand moderate and economic growth slow and we are closely monitoring the impact of reduced discretionary spending, particularly on our small and medium-sized business customers.

A very good result from CBA.

Commonwealth Bank (ASX: CBA)

Bowen Coking Coal (ASX: BCB) 9.3c

BCB +10.71%: the Queensland coal company provided an update on shipping which helped stop the slide in shares today following weakness stemming from board and balance sheet issues. Bowen said it had shipped 179kt of coal in July and was confident much of the supply chain issues that have plagued the company are behind them. The shipments will bring in important revenue that should help to ease the balance sheet concerns the company was facing, having drawn down most of a $US55m facility on 30 June despite having $47m in cash at the end of FY23. Maintaining these shipping rates at a minimum will go a long way to solving Bowens near term concerns. The company also upgraded the resource at Hillalong South by 45% today, though that news was playing second fiddle.

Bowen Coking Coal (ASX: BCB)

Broker moves

  • Woodside Energy Cut to Underweight at Jarden Securities
  • Lovisa Cut to Neutral at Macquarie; PT A$22
  • Charter Hall Long WALE Raised to Neutral at Macquarie; PT A$3.56
  • HMC Capital Cut to Hold at Jefferies; PT A$5.20
  • Dexus Cut to Hold at Jefferies; PT A$8.78
  • James Hardie GDRs Raised to Hold at Jefferies; PT A$43.30
  • Woodside Energy Cut to Neutral at Evans & Partners Pty Ltd
  • Pilbara Minerals Raised to Add at Morgans Financial Limited

Major movers today

Have a great night

The Market Matters Team


Make informed investment decisions

At Market Matters, we write a straight-talking, concise, twice daily note about our experiences, the stocks we like, the stocks we don’t, the themes that you should be across and the risks as we see them. Click here for your free trial.

The Match Out will be available each day after the market close. Follow my profile to be notified when the latest report is live.

........
Livewire gives readers access to information and educational content provided by financial services professionals and companies (“Livewire Contributors”). Livewire does not operate under an Australian financial services licence and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any advice given. Any advice on this site is general in nature and does not take into consideration your objectives, financial situation or needs. Before making a decision please consider these and any relevant Product Disclosure Statement. Livewire has commercial relationships with some Livewire Contributors.

James Gerrish
Portfolio Manager
Market Matters

James is the Lead Portfolio Manager & primary author at Market Matters, a digital advice & investment platform with over 2500 members that offers real market intel & portfolios open for investment. He is also a Senior Portfolio Manager at Shaw and...

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

Comments

Sign In or Join Free to comment